Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Factors of ED and Tadalafil Response in Diabetes
NCT06520839Phase 3Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil in erectile dysfunction (ED), sponsored by University Medical Centre Ljubljana. Started May 2024; status: recruiting.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06520839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06520839.